entertainment -WSS

entertainment

author：knowledge 2025-09-30 00:09:45 - browse：51

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Ask STAT: What do you want to know about ChatGPT in medicine?

WSS

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

The strategy behind pharma's lawsuits over drug pricing reform

Truvian presents data for its desktop blood

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Biogen says it will cut costs by $700 million, slash 1,000 jobs

The science behind Janet Jackson's pregnancy at 49

entertainment

entertainment

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Cloning humans is technically possible. It's curious no one has tried

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New lawsuit accuses health insurer Cigna of denying claims in bulk

Hepatitis C has a cure — but many Americans still lack access to it

WATCH: Why do fingernails fall off when they're damaged?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Democrats decry new health bill for going easy on private equity

In age of alternative facts, a scholarly course on calling out crap

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Dems pitch expanding Medicare power to negotiate drug prices

Senate panel puts off hardest PBM reforms for another day

The haunting brain science of long Covid

#NeedHerScience: shining a light on gender disparities in medicine

Paxlovid study fails to answer questions over benefit for broader groups

CDC Director Mandy Cohen on transparency, trust, and health

leisure time

hotspot

entertainment

Wikipedia